Overview the venom compositions and bioactivities of the predatory ant *Odontomachus monticola*.

1. Introduction {#sec1-toxins-11-00050}
===============

Ants (Hymenoptera: Formicidae) have been believed to share the same ancestor with bees and wasps, and have many traits in common with them. Since most ant species have a sting with venoms including formic acid, hydrocarbons, amines, peptides, and proteins, for predatory purpose \[[@B1-toxins-11-00050]\], the venom components have been attractive as potential lead compounds for drug development. One of the peptide components in the ant venom is the pilosulin-like peptide. Since Donovan et al. isolated pilosulin 1 cDNA from a *Myrmecia pilosula* cDNA library in 1993 \[[@B2-toxins-11-00050]\], many pilosulin and pilosulin-like peptides have been identified from various ant species \[[@B3-toxins-11-00050],[@B4-toxins-11-00050],[@B5-toxins-11-00050]\]. Some of the pilosulins and pilosulin-like peptides formed homo- or heterodimers by single or double disulfide bridges, and displayed various bioactivities \[[@B2-toxins-11-00050],[@B6-toxins-11-00050],[@B7-toxins-11-00050]\].

*Odontomachus monticola*, a predatory ant species in the subfamily Ponerinae, is about 10 mm long, red-brown in color, and has long mandibles \[[@B8-toxins-11-00050]\]. They prey on other insects using their venomous stings, which cause intense pain and prolonged itching in humans. In 2016, Aili et al. reported 528 molecular masses, including 27 disulfide-bonded, without information on their primary structures or biological activities, in the venom of *O. hastatus* by LC-MS analysis \[[@B9-toxins-11-00050]\]. On the other hand, we identified 92 toxin-like peptides and proteins including pilosulin-like peptides 1--6 from *O. monticola* by transcriptome and peptidome analysis \[[@B10-toxins-11-00050]\]. Despite the transcriptome and limited peptidome analysis, the venom components of the ant genus *Odontomachus* have not been fully understood.

In this study, we further analyzed the venom and venom sac extract by ESI-MS/MS with or without trypsin digestion and reducing agent. Our results uncovered 1244 molecular masses, including toxin-like peptides and toxin-like proteins in the venom and venom sac extract of *O. monticola* by ESI-MS/MS without trypsin digestion, and also confirmed the amino acid sequences, amidation, processing, and dimerization with a single disulfide bridge of pilosulin-like peptides. Furthermore, we characterized the physicochemical and biological properties of pilosulin-like peptides. Some of the pilosulin-like peptides have a cationic amphiphilic region and displayed antimicrobial, hemolytic, and histamine-releasing activities.

2. Results and Discussion {#sec2-toxins-11-00050}
=========================

2.1. Low-Molecular-Mass Components in O. monticola Venom and Venom Sac Extract {#sec2dot1-toxins-11-00050}
------------------------------------------------------------------------------

Among the low-mass components, we found two biogenic amines (histamine and tyramine) and three amino acids (leucine/isoleucine, phenylalanine, and tryptophan) in the venom and venom sac extract of *O. monticola* by retention time comparison and elemental analysis ([Figure 1](#toxins-11-00050-f001){ref-type="fig"}).

Histamine and tyramine interact with their specific receptors and activate specific neurons, being major neurotransmitters in insects, to regulate physiology and behavior. In addition, histamine is partly involved in pain-producing and itching reactions \[[@B11-toxins-11-00050]\]. According to the early studies about ant venoms, histamine has been detected in several ant species \[[@B12-toxins-11-00050]\]. In *Myrmecia pyriformis*, histamine accounted for approximately 2% of venom dry weight \[[@B13-toxins-11-00050]\]. Histamine might be a major and common biogenic amine in ant venoms. Glutamic acid, a neurotransmitter and neurotoxin, was a major and common component in the venoms of five ant species, *Myrmica ruginodis*, *Pogonomyrmex badins*, *Solenopsis saevissima*, *Tetramorium guineense*, and *T. caespitum* L \[[@B12-toxins-11-00050]\], but did not exist in the venom and venom sac extract of *O. monticola*. Most of the ant species might have biogenic amines and amino acids in various combinations. Although social and solitary wasps often have nucleosides (e.g., adenosine and guanosine) and nucleotides (e.g., AMP and ADP), this ant species lacks these compounds in its venom \[[@B14-toxins-11-00050]\].

2.2. Overview of High-Molecular-Mass Components in Venom and Venom Sac Extract {#sec2dot2-toxins-11-00050}
------------------------------------------------------------------------------

We determined the amino acid sequences from ESI-MS/MS data and searched the amino acid sequences using PEAKS 8.5 against the major 192 components from *O. monticola* venom gland transcriptome data ([Table S1](#app1-toxins-11-00050){ref-type="app"}). These components were selected from the transcripts which have high relative expression level in the transcriptome analysis or have some similarities with the transcripts of well-known toxins. MS/MS analysis under reducing and nonreducing conditions without trypsin digestion yielded 973 and 517 amino acid sequences (247 overwrapped sequences), respectively. Overall, 545 sequences from a total of 1244 sequences were derived from pilosulin-like peptides.

From the 1244 sequences, 193 were mapped to 50 high-molecular-mass components other than pilosulin-like peptides. The amino acid sequences from MS/MS data without trypsin digestion suggests that some of the proteins might be partially degraded before or after the extraction step. Due to the limited number of sequences in the reference database of the PEAKS 8.5 software, we considered that many of the de novo amino acid sequences were not assigned. Next, we searched the de novo amino acid sequences against 41,764 contig sequences of transcriptome analysis \[[@B10-toxins-11-00050]\] with the tbalstn program to prevent oversight. In this way, 109 sequences were additionally mapped to 70 high-molecular-mass components other than pilosulin-like peptides ([Table S2](#app1-toxins-11-00050){ref-type="app"}), and 397 sequences were unassigned. Including the MS/MS data with trypsin digestion with the data without trypsin digestion, the amino acid sequences were mapped to 104 components other than pilosulin-like peptides in the venom and venom sac extract by PEAKS 8.5 ([Table 1](#toxins-11-00050-t001){ref-type="table"}). The total number of components identified from mass spectrometry analysis (183) is much smaller than that of contigs yielded from transcriptome analysis (41,764).

Collecting the venom by electrostimulation has been successful in some large ant species \[[@B5-toxins-11-00050]\]. Since most ant species are too small to apply electrostimulation for collecting venom, a method of dissecting and extracting the venom sac has been applied to collect venoms in many ant species. Because we collected the venom from dissected venom sacs, membrane proteins, cytoskeleton proteins, DNA-binding proteins, translation-related proteins, and replication-related proteins are not believed to represent venom components and are most likely contaminants from venom sac tissue.

The rest of the components were roughly classified into three groups: toxin-like components, non-toxin-like components, and uncharacterized components. Among the toxin-like components we found pilosulin-like peptides, phospholipase A~2~s, hyaluronidase, and venom dipeptidyl peptidases of which amino acid sequences have some similarities to those of *Apis mellifera* orthologues in our previous study \[[@B10-toxins-11-00050]\]. These proteins might function in tissue damage, venom diffusion, and venom maturation. Nontoxin-like components included cytochrome P450s and pheromone-binding proteins.

According to the classification of the venom components in *Solenopsis invicta* \[[@B15-toxins-11-00050]\], these proteins might be classified into the groups of self-venom protection and chemical communication for alarm. Among uncharacterized components, we found uncharacterized proteins 1, 3, and 4. Uncharacterized protein 3 has nine cysteine residues, like some of the well-characterized toxins which are rich in cysteine residues, allowing them form unique conformations \[[@B16-toxins-11-00050],[@B17-toxins-11-00050]\].

2.3. Novel Pilosulin-Like Peptides {#sec2dot3-toxins-11-00050}
----------------------------------

MS/MS analysis under reducing and nonreducing conditions without trypsin digestion showed that 545 sequences of 1244 total sequences were derived from pilosulin-like peptides; pilosulin-like peptides 1, 2, 3, 4, 5, and 6 have 47, 124, 98, 82, 34, and 101 derivatives, respectively. They included the precursors and degradation products ([Table 2](#toxins-11-00050-t002){ref-type="table"}; [Figure 2](#toxins-11-00050-f002){ref-type="fig"}B; [Figures S1--S6](#app1-toxins-11-00050){ref-type="app"}). Because pilosulin-like peptides 2 and 3 have closely related amino acid sequences, they share five common derivatives ([Table 2](#toxins-11-00050-t002){ref-type="table"}; [Figures S2 and S3](#app1-toxins-11-00050){ref-type="app"}). Furthermore, we found three novel pilosulin-like peptides in the de novo amino acid sequences, which we termed pilosulin-like peptides 7, 8, and 9 ([Figure 2](#toxins-11-00050-f002){ref-type="fig"}A). To isolate pilosulin-like peptides 7 and 8 cDNAs, we revised raw reads of the transcriptome data in our previous study and found several reads corresponding to pilosulin-like peptides 7 and 8. cDNA clones of pilosulin-like peptides 7 and 8 were isolated by RT-PCR ([Figures S10 and S11](#app1-toxins-11-00050){ref-type="app"}), indicating that pilosulin-like peptides 4 and 7 and pilosulin-like peptides 5 and 8 each have related nucleotide sequences. Accordingly, four nucleotide sequences (pilosulin-like peptides 4, 5, 7, and 8) were integrated into two sequences (pilosulin-like peptides 4 and 5) by the cd-hit-est software during the assembly process of transcriptome analysis \[[@B10-toxins-11-00050]\]. Pilosulin-like peptides 7 and 8 have 83 and 27 derivatives in the 1244 sequences, respectively. Pilosulin-like peptides 4 and 7 and pilosulin-like peptides 5 and 8 share 41 and 5 common derivatives, respectively ([Table 2](#toxins-11-00050-t002){ref-type="table"}; [Figure 2](#toxins-11-00050-f002){ref-type="fig"}B; [Figures S7 and S8](#app1-toxins-11-00050){ref-type="app"}).

We found pilosulin-like peptide 9 in the annotation of de novo amino acid sequences. The unassigned de novo amino acid sequences of MS/MS analysis with trypsin digestion were compared against 41,764 contig sequences of transcriptome analysis \[[@B10-toxins-11-00050]\] by the tblastn program. One of the amino acid sequences (Met-Tyr-Gln-Gly-Leu-Gly-Glu-Lys) ([Figure S9](#app1-toxins-11-00050){ref-type="app"}) was matched to the contig Om11177_c0_g1_i2, which was annotated to aspartyl/glutamyl tRNA in our previous study \[[@B10-toxins-11-00050]\]. Although tRNAs must be eliminated during the extraction step of total RNA and must not be transcribed by reverse transcriptase, the relative expression level of Om11177_c0_g1_i2 was high and accounted for 1.3% of all reads; so, we considered the contig Om11177_c0_g1_i2 as being a misassembled product of the Trinity software.

We selected the raw reads that encoded the amino acid sequence Met-Tyr-Gln-Gly-Leu-Gly-Glu-Lys and manually assembled the selected reads. The assembled nucleotide sequence encoded a similar leader sequence with pilosulin-like peptides 1--8, and we considered the manually assembled contig as encoding a novel member of the pilosulin-like peptide family. Using the contig sequence, we designed oligonucleotide primers and isolated a DNA fragment encoding the entire open reading frame (ORF) of pilosulin-like peptide 9 by RT-PCR ([Figure S12](#app1-toxins-11-00050){ref-type="app"}).

Interestingly, the cDNA of pilosulin-like peptide 9 had a structure in which a nucleotide sequence (5′-ATGTACCAAG-3′) was inserted between the nucleotide positions 214 and 215 of the pilosulin-like peptide 1 cDNA. As the result of insertion and frame shifting, the downstream amino acid sequence of pilosulin-like peptide 9 is far different from that of pilosulin-like peptide 1. This may indicate the process of diversification of pilosulin-like peptides. Although we predicted an amino acid sequence of the mature peptide from the nucleotide sequence, only a partial amino acid sequence of pilosulin-like peptide 9 has been confirmed by MS/MS analysis.

2.4. Mature Forms of Pilosulin-Like Peptides {#sec2dot4-toxins-11-00050}
--------------------------------------------

In our previous study, we predicted the N-termini of every mature pilosulin-like peptide, the elimination of Lys residues at the C-termini, and the amidation at the C-termini of some of the mature pilosulin-like peptides \[[@B10-toxins-11-00050]\]. Signal peptidase, dipeptidyl peptidase, amidatinglyase, and carboxypeptidase, some of which are detected by ESI-MS/MS analysis ([Table 1](#toxins-11-00050-t001){ref-type="table"} and [Table S2](#app1-toxins-11-00050){ref-type="app"}), might be involved in the processing and modification of pilosulin-like peptides ([Figure 2](#toxins-11-00050-f002){ref-type="fig"}A). The peptides of highest or second-highest signal intensity corresponded to the predicted mature peptides by nucleotide sequences. Since the signal intensity is affected by the abundance of the peptide in the venom and venom sac extract, the peptides of highest or second-highest signal intensity might be the major components in the venom. In addition to the mature peptides, we found the precursors of pilosulin-like peptides that have Gly or Gly--Lys residues at the C-termini and the degradation products of pilosulin-like peptides ([Table 2](#toxins-11-00050-t002){ref-type="table"}). We compared the LC-ESI-MS profile of the crude venom and venom sac extract under reducing and nonreducing conditions. A broad peak (retention time around 31.58 min), which consisted of three masses (6331.6249, 6349.6355, and 6367.6460) under the nonreducing condition, was divided into two peaks (retention time 28.14 and 28.80 min), which consisted of two masses (3223.8418 and 3241.7983) under the reducing condition ([Figure 3](#toxins-11-00050-f003){ref-type="fig"}). These observed molecular masses were identical to the theoretical masses of mature pilosulin-like peptides 4 and 7 monomers, respectively. Consequently, we confirmed that pilosulin-like peptides 4 and 7 formed a homo- or heterodimer by a disulfide bridge ([Figure 4](#toxins-11-00050-f004){ref-type="fig"}).

2.5. Structural and Physicochemical Properties of Pilosulin-Like Peptides {#sec2dot5-toxins-11-00050}
-------------------------------------------------------------------------

Pilosulins are α-helical cationic antimicrobial peptides \[[@B2-toxins-11-00050],[@B6-toxins-11-00050],[@B7-toxins-11-00050]\]. We examined the secondary structure of pilosulin-like peptides using Proteus \[[@B18-toxins-11-00050]\]. Proteus showed that mature regions of pilosulin-like peptides 1--8 are α-helical structures, but pilosulin-like peptide 9 is a coiled-coil structure. The pI of the mature pilosulin-like peptides, without consideration of amidation at C-termini, was calculated with IPC \[[@B19-toxins-11-00050]\]. IPC demonstrated that the mature pilosulin-like peptides 5 and 8 are acidic peptides (calculated pI = 5.98) and the others are basic peptides. The calculated pIs of the mature pilosulin-like peptides 1, 2, 3, 4, 6, 7, and 9 are 8.46, 8.89, 9.06, 9.18, 9.96, 9.18, and 8.46, respectively. Taken together, pilosulin-like peptides 1--4, 6, and 7 may function as α-helical cationic antimicrobial peptides. To test whether pilosulin-like peptides have a cationic, amphiphilic helical conformation, the net charge and hydrophobic indexes of pilosulin-like peptides were examined using HeliQuest \[[@B20-toxins-11-00050]\]. Parameters to search cationic amphipathic α-helix regions of pilosulin-like peptides were determined based on a well-known cationic amphipathic antimicrobial peptide, cecropin A (GenBank accession No. AAA29185): hydrophobicity 0--0.6, hydrophobic moment 0.1--1.0, and net charge 3--10. HeliQuest found cationic amphipathic α-helix sequences in pilosulin-like peptides 2--4, 6, and 7 ([Figure 5](#toxins-11-00050-f005){ref-type="fig"}A). Furthermore, helical wheel projections demonstrated that they are typical cationic α-helical amphiphilic peptides, in which hydrophobic amino acids are located on one side and basic amino acids are on the other side ([Figure 5](#toxins-11-00050-f005){ref-type="fig"}B). However, HeliQuest could not find an α-helical region that showed a typical cationic amphiphilic peptide in pilosulin-like peptide 1, since the mature form of pilosulin-like peptide 1 is shorter than the default setting (18 amino acids) of HeliQuest and the net charge is less than two.

2.6. Biological Activities of Pilosulin-Like Peptides {#sec2dot6-toxins-11-00050}
-----------------------------------------------------

Pilosulin-like peptides 1--6 were chemically synthesized by the 9-fluorenylmethyloxycarbonyl (Fmoc) method, and we examined their biological activities ([Table 3](#toxins-11-00050-t003){ref-type="table"}). We synthesized homodimeric pilosulin-like peptide 4, which was linked by a single disulfide bond. Pilosulin-like peptides 1--4 and 6 with a cationic α-helix displayed antimicrobial activities against *Escherichia coli* and *Staphylococcus aureus*. These activities were higher than those of magainin, a well-known *Xenopus laevis* antimicrobial peptide \[[@B21-toxins-11-00050]\]. Interestingly, pilosulin-like peptide 4 also had high antimicrobial activities against *Saccharomyces cerevisiae*. In support of these experimental results, the antifungal peptide prediction server Antifp predicted that pilosulin-like peptide 4, but not other pilosulin-like peptides, was an antifungal peptide \[[@B22-toxins-11-00050]\]. Virtual alanine scanning of pilosulin-like peptide 4 by Antifp revealed that the replacement of a cysteine residue remarkably reduced the index of antifungal activity. Cysteine residues are known to be abundant in antifungal peptides in general \[[@B22-toxins-11-00050]\], and the replacement of cysteine with serine in brevinin-1B Ya, a frog antimicrobial peptide, reduced the antifungal activity \[[@B23-toxins-11-00050]\]. The cysteine residue of pilosulin-like peptide 4 may be important for antifungal activity.

Pilosulin-like peptide 5 with an acidic α-helix had no or low antimicrobial activities against all the microbes tested in this study, but had the highest hemolytic activity among pilosulin-like peptides 1--6. This hemolytic activity may depend on higher hydrophobicity. Previous studies suggested a correlation between peptide hydrophobicity and hemolytic activity \[[@B25-toxins-11-00050]\]. For example, melittin, a honey bee hemolytic peptide, shows a higher hydrophobicity (0.45--0.88). Hydrophobicity of pilosulin-like peptide 5 is 0.914, which is the highest among pilosulin-like peptides.

Pilosulin-like peptides are major components of *O. monticola* venom sac extract. The first step in the antimicrobial mechanism has been suggested to be these peptides binding to the anionic phospholipids that are abundant in bacterial membranes, which is then followed by pore formation by α-helical cationic peptides as the second step \[[@B26-toxins-11-00050]\]. The variations of antimicrobial activities might reflect on the difference of the physicochemical properties among pilosulin-like peptides.

Pilosulin-like peptide 4 had histamine-releasing activity against rat mast cells comparable to that of melittin, which displays histamine-releasing activity.

3. Conclusions {#sec3-toxins-11-00050}
==============

In this study, we have analyzed the venom and venom sac extract of *O. monticola* by mass spectrometry analysis. Because of the high sensitivity of the analysis, the extract accounting for just one fifth of a venom sac was enough for a single MS/MS analysis. We determined 1244 amino acid sequences by ESI-MS/MS analysis without trypsin digestion. In total, 545 of them were derived from pilosulin-like peptides 1--8, and 302 amino acid sequences corresponded to the high molecular mass components that were identified from our previous transcriptome analysis. This MS/MS analysis suggests that the majority of the venom components might be 2--6.5-kDa peptides.

Synthetic pilosulin-like peptides 1--4 and 6 displayed antimicrobial and histamine-releasing activities. Moreover, pilosulin-like peptide 5 showed the highest hemolytic activity among pilosulin-like peptides. Some of the ant toxins show various biological activities, such as neurotoxic \[[@B27-toxins-11-00050],[@B28-toxins-11-00050]\] and enzymatic activity \[[@B29-toxins-11-00050]\]. In future studies, we will further explore the multiple activities of pilosulin-like peptides.

4. Materials and Methods {#sec4-toxins-11-00050}
========================

4.1. Ants {#sec4dot1-toxins-11-00050}
---------

One *O. monticola* colony was collected in Musashimurayama, Tokyo, Japan, on 1 July 2016. The species was morphologically identified.

4.2. Liquid Chromatography-Mass Spectrometry (LC-MS) Analysis for Low-Molecular-Weight Components {#sec4dot2-toxins-11-00050}
-------------------------------------------------------------------------------------------------

Twenty *O. monticola* venom sacs were collected and extracted with 50% acetonitrile containing 0.1% (*v*/*v*) trifluoroacetic acid (50 μL) for 2 h at 4 °C. A single venom sac contains 50--150 nL of venom. The extract was passed through a 0.45-μm filter and successively diluted with the extraction solvent to a final concentration of 0.04 sacs/μL. This dilution was used for the LC-MS analysis. The LC conditions were: solvent A, 0.1% (*v*/*v*) aqueous formic acid; solvent B, 0.1% (*v*/*v*) formic acid in acetonitrile; 5--65% linear gradient of solvent B in solvent A at a flow rate of 200 μL/min; column, Capcell Pak C18 UG 120 (1.5 × 150 mm, Shiseido, Tokyo, Japan); column temperature, 25 °C. The molecular weights of the ant peptides were verified by LTQ Orbitrap XL-ETD (Thermo Fisher Scientific, Waltham, MA, USA). The MS conditions were: ionization, electrospray in positive mode; ion spray voltage, 4.6 kV; capillary temperature, 350 °C; capillary and tube lens voltages, 19 V and 35 V, respectively; detector, an Orbitrap at a resolution of 60,000 at *m*/*z* 400. MS scan range was *m*/*z* 100--2000. The mass spectrometer was calibrated with polytyrosine, and the resolution was usually 1--3 ppm after measurement.

4.3. Liquid Chromatography-Mass Spectrometry (LC-MS) Analysis for Peptide and Protein Components {#sec4dot3-toxins-11-00050}
------------------------------------------------------------------------------------------------

After filtration of the venom sac extract, the extract was diluted 10 times with 50 mM ammonium bicarbonate, pH 8.0, to improve separation and prevent peak tailing in HPLC. The diluted extract was reduced with DTT at a concentration of 10 mM (Thermo Fisher Scientific), alkylated with iodoacetamide at a concentration of 20 mM (Thermo Fisher Scientific), or digested by trypsin at a concentration of ca. 30 μg/mL (Promega, Madison, WI, USA) overnight at 37 °C. Separation was achieved by Zaplous α pep C18 analytical column (3 μm 120A, 1.5 × 150 mm, AMR, Tokyo, Japan) with L-Trap column (5 μm, 0.3 × 5 mm, AMR, Tokyo, Japan) at a flow rate of 500 μL/min using two mobile phases, 0.1% (*v*/*v*) aqueous formic acid (solvent A) and 0.1% (*v*/*v*) formic acid in acetonitrile (solvent B). The following gradient was used: 0--60 min, 5--65% solvent B; 60--70 min, 65--95% solvent B; 70--80 min, 95% solvent B.

The molecular weights of the ant peptides were verified by Q Exactive (Thermo Fisher Scientific, Waltham, MA, USA). The MS conditions were: ionization, nanoelectrospray (CaptiveSpray Ionization: CSI) in positive mode; ion spray voltage, 1.4 kV; capillary temperature, 250 °C; S-lens level, 50; detector, an Orbitrap at a resolution of 70,000 from *m*/*z* 350--2000. The mass spectrometer was calibrated with a calibrant of LTQ Velos ESI Positive Ion Calibration Solution (Thermo Fisher Scientific), and the mass accuracy was usually 1--3 ppm after measurement. The raw mass spectrum was processed by using Xcalibur (Thermo Fisher Scientific). Peptide sequences were determined from MS/MS spectra by PEAKS 8.5 (Bioinformatics Solutions, Waterloo, Canada; parent mass error tolerance 10.0 ppm, fragment mass error tolerance 0.02 Da, score threshold 15.0) and manually checked. We selected 192 amino acid sequences derived from major transcripts in the venom gland transcriptome analysis and the 116 amino acid sequences of common external contaminants from cRAP (Global Proteome Machine Organization). After construction of a FASTA format file including 308 amino acid sequences, the file was incorporated into PEAKS 8.5 software as the reference database.

To assign the de novo amino acid sequences, tblastn (parameters: *E*-value 0.1, matrix PAM40, word size 3) was performed using 41,764 contig sequences of transcriptome analysis.

4.4. Pilosulin-Like Peptides 7--9 cDNA Cloning and Sequencing {#sec4dot4-toxins-11-00050}
-------------------------------------------------------------

Total RNA isolated from the ant venom glands with sacs was reverse-transcribed to cDNA and amplified by PCR with KOD-Plus-Neo (Toyobo, Osaka, Japan). The oligonucleotide primers used for pilosulin-like peptide 7 were Pilo U1 (5′-ATGAAACCGTCGGGTATCAC-3′), corresponding to nucleotides (nt) 9--28 of pilosulin-like peptide 2; 41CPas (5′-TTGCTTTACGTATCCCAT-3′); 41CP (5′-CCAAAGCGTGTGGACTGA-3′); and Oligo-dT (5′-GAGTCGACTCGAGAA(T)17-3′). 41CP and 41CPas primers were designed from transcriptome analysis data and the amino acid sequences: Met-Gly-Tyr-Val-Lys-Gln; Lys-Ala-Cys-Gly-Leu-Met. The oligonucleotide primers used for pilosulin-like peptide 8 were 51S (5′-TATGTGTGAAAGCTCTTC-3′) and 51AS (5′-CCAATGTAATGCCAATCG-3′), designed based on the 5′ and 3′ untranslated regions predicted by transcriptome analysis. The oligonucleotide primers used for pilosulin-like peptide 9 were Pilo U1, 9CPas (5′-CCCCAGTCCTTGGTACAT-3′), 9CP (5′-ATGTACCAAGGACTGGGG-3′), and Oligo-dT. 9CP and 9CPas primers were designed from the transcriptome analysis data and the amino acid sequence: Met-Tyr-Gln-Gly-Leu-Gly-Glu-Lys. The amplified products of the cDNAs were cloned into the EcoRI site of pBluescript II SK(-) (Agilent Technologies, La Jolla, CA, USA). All inserts were sequenced using a Model 3500 Genetic Analyzer (Thermo Fisher Scientific, Waltham, MA, USA).

4.5. Synthesis and Biological Activities of Pilosulin-Like Peptides {#sec4dot5-toxins-11-00050}
-------------------------------------------------------------------

Pilosulin-like peptides 1--6 were prepared using Fmoc chemistry by GenScript (Nanjing, Jiangsu, China). The peptides were purified by RP-HPLC with a preparative C18 column. The purity and molecular weight of the final peptides were verified by HPLC and MS. Antimicrobial, hemolytic, and histamine-releasing activities were measured as described previously \[[@B6-toxins-11-00050]\].

4.6. WEB Server Used to Analyze the Physiochemical Properties {#sec4dot6-toxins-11-00050}
-------------------------------------------------------------

Secondary structure prediction was performed by Proteus (<http://www.proteus2.ca/proteus/>). The pI of peptides was calculated with IPC (<http://isoelectric.org/index.html>). The physicochemical properties were examined using HeliQuest (<http://heliquest.ipmc.cnrs.fr/>). The antifungal peptide prediction was carried out using the Antifp server (<http://webs.iiitd.edu.in/raghava/antifp/index.html>).
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![Low-molecular-mass components of *O. monticola* venom and venom sac extract as analyzed by LC-ESI-MS. (**A**) Selected ion chromatograms of total ion chromatogram, (**B**) leucine/isoleucine, (**C**) phenylalanine, (**D**) tryptophan, (**E**) histamine, and (**F**) tyramine. The observed and calculated *m/z* values are shown with the corresponding structural formulae.](toxins-11-00050-g001){#toxins-11-00050-f001}

![Multiple alignment, identity matrix, and phylogenic analysis of pilosulin-like peptides. (**A**) The amino acid sequences of melittin and pilosulin-like peptides were aligned with ClustalW in Lasergene 12 (DNASTAR, Madison, WI, USA) and manually modified. Arrows indicate the putative processing and modification sites for signal peptidase, dipeptidyl peptidase, amidatinglyase, and carboxypeptidase. Proline and alanine residues in the spacer region between the signal and mature peptides of pilosulin-related peptides are highlighted in yellow. Nucleotide sequences for pilosulin-like peptides 7, 8, and 9 were assigned DDBJ/EMBL/GenBank Accession Numbers LC416796--LC416798, respectively. (**B**) Percentage amino acid sequence identities between melittin and pilosulin-like peptides are shown. (**C**) The alignment of pilosulin-like peptides, pilosulin 1, and melittin precursors by ClustalV in Lasergene 12 was used to construct a phylogenic tree using the neighbor-joining (NJ) method. The phylogenic tree rooted with the amino acid sequence of melittin. The numbers above the branches indicate the percentage of 1000 bootstrap replicates.](toxins-11-00050-g002){#toxins-11-00050-f002}

![High-molecular-mass components of *O. monticola* venom and venom sac extract as analyzed by LC-ESI-MS. (**A**) The patterns of the total ion current of *O. monticola* venom and venom sac extract under nonreducing and (**B**) reducing conditions are shown. Peaks containing pilosulin-like peptides are labeled by arrows.](toxins-11-00050-g003){#toxins-11-00050-f003}

![Dimer formation of pilosulin-like peptides 4 and 7. Monomers of pilosulin-like peptides 4 and 7 were connected by a disulfide bridge at the amino acid position 21. Unique amino acid residues in pilosulin-like peptides 4 and 7 are highlighted in yellow and red, respectively. C**\*** indicates S-(carbamoylmethyl)-L-cysteine.](toxins-11-00050-g004){#toxins-11-00050-f004}

![Amino acid sequences and helical wheel projection of pilosulin-like peptides 2, 3, 4, 6, and 7. (**A**) Amino acid sequences of mature pilosulin-like peptides. The cationic amphipathic helix regions in pilosulin-like peptides (PLP) 2, 3, 4, 6, and 7 predicted by HeliQuest are highlighted in red. (**B**) Helical wheel projections of pilosulin-like peptides 2, 3, 4, 6, and 7 drawn by HeliQuest. Nonpolar amino acids (F, I, L, M, V, and W), basic amino acids (K), acidic amino acids (D), small polar amino acids (A and G), aromatic polar amino acids (H), hydroxyl-containing polar amino acids (S and T), amide-containing polar amino acids (N), and proline (P) are highlighted by yellow, blue, red, gray, sky-blue, purple, pink, and green color, respectively.](toxins-11-00050-g005){#toxins-11-00050-f005}

toxins-11-00050-t001_Table 1

###### 

High-molecular-mass components in the venom and venom sac extract detected by LC-ESI-MS.

  Peptide/Protein                                     Accession Number   Coverage (%) ^a^             
  --------------------------------------------------- ------------------ ------------------ ---- ---- ----
  acetylcholine esterase                              FX985608                                   1    
  apolipophorin 1                                     FX985561           2                  4    8    7
  apolipophorin 2                                     FX985562                              10   61   29
  calcium-independent phospholipase A~2~ gamma        FX985510           12                      7    7
  carboxypeptidase D                                  FX985540                              5    4    4
  carboxypeptidase Q                                  FX985538                                   67   26
  CDV3 homolog                                        FX986049                              8         
  chymotrypsin inhibitor 1                            FX986026                                        11
  cytochrome P450 1                                   FX985568           10                      5    4
  cytochrome P450 3                                   FX985570                                   11   
  cytochrome P450 4                                   FX985571                                   4    
  cytochrome P450 5                                   FX985572                              9    6    9
  cytochrome P450 6                                   FX985573                              5         2
  cytosolic carboxypeptidase-like protein 5           FX985541                                   4    7
  dishevelled homolog 3                               FX986050                                   3    4
  hyaluronidase                                       FX985505                              5    68   47
  lysosomal ProX carboxypeptidase                     FX985539                                   3    7
  matrix metalloproteinase 14                         FX985528                                   20   18
  NADPH cytochrome P450 reductase                     FX985574           5                       6    5
  neuroblastoma suppressor of tumorigenicity 1        FX986056                                   7    
  neuropeptide-like 1                                 FX986015                                   7    7
  peptidyl-prolyl cis-trans isomerase 1               FX986028                                   22   17
  peptidyl-prolyl cis-trans isomerase 2               FX986029                                   4    
  peptidyl-prolyl cis-trans isomerase 3               FX986030                                   3    8
  peptidyl-prolyl cis-trans isomerase 4               FX986031                                   7    8
  peptidyl-prolyl cis-trans isomerase 5               FX986032                                   6    7
  peptidyl-prolyl cis-trans isomerase 7               FX986034                                   1    
  peptidyl-prolyl cis-trans isomerase 8               FX986035           38                           
  pheromone binding protein 1                         FX985594                                        14
  pheromone binding protein 2                         FX985595                                   11   
  pheromone binding protein 3                         FX985596                                   20   
  pheromone binding protein 4                         FX985597                                   16   
  pheromone binding protein 6                         FX985599                              4         
  phospholipase A~2~ isozyme 2                        FX985507                              11   36   40
  protein disulfide isomerase 1                       FX985548                              8    14   8
  protein disulfide isomerase 2                       FX985549           19                      8    
  royal jelly protein                                 FX986021                                        9
  UDP glucuronosyltransferase 2C1                     FX986048                                   14   4
  uncharacterized protein 1                           FX985636           4                  5    3    6
  uncharacterized protein 3                           FX986042                                   19   64
  uncharacterized protein 4                           FX986043                                   54   64
  UPF0518 protein                                     FX986054           4                  3    3    2
  VEGF ^C^-like protein                               FX985521                                   6    
  venom allergen 1                                    FX985511                              7         
  venom allergen 2                                    FX985512                                   5    
  venom allergen 3                                    FX985513                                   21   5
  venom dipeptidyl peptidase 1                        FX985542                                   4    12
  venom dipeptidyl peptidase 2                        FX985543                                   4    4
  venom dipeptidyl peptidase 3                        FX985544                              10   3    5
  venom serine carboxypeptidase                       FX985537                                   3    
  venom serine protease 2                             FX985523                              5         
  venom serine protease 3                             FX985524                                   6    
  very high density protein 1                         FX985566           3                  3    3    4
  very high density protein 2                         FX985567                              3    5    
  vitellogenin 1                                      FX985563           3                  5    5    2
  vitellogenin 2                                      FX985564                                   10   
  waprin 1                                            FX985515                                   22   
  waprin 2                                            FX985516                                   7    11
  40S ribosomal protein SA \*                         FX985616           8                            8
  60S acidic ribosomal protein P0 \*                  FX985621           22                 6         3
  60S ribosomal protein L10 \*                        FX985634                                        11
  60S ribosomal protein L3 \*                         FX985633                              10        7
  60S ribosomal protein L34 \*                        FX985627                                   16   
  60S ribosomal protein L36 \*                        FX985629                                   15   
  60S ribosomal protein L4 \*                         FX985618                                   5    8
  60S ribosomal protein L6 \*                         FX985625                                   5    11
  60S ribosomal protein L7 \*                         FX985622                                        12
  60S ribosomal protein L7a \*                        FX985617                                        13
  60S ribosomal protein L9 \*                         FX985635                                        10
  actin, muscle \*                                    FX985587                              13   7    7
  ATPase WRNIP1 \*                                    FX986047                                   13   
  elongation factor 1-alpha \*                        FX985554           10                      6    
  elongation factor 1-beta \*                         FX985557                              5         
  elongation factor 1-delta \*                        FX985559                                   8    29
  elongation factor 1-gamma \*                        FX985555           20                      8    2
  elongation factor 2 \*                              FX985553           4                  4    2    8
  elongation factor G, mitochondrial \*               FX985558                              2    11   
  elongation factor Tu, mitochondrial \*              FX985556                              10        3
  histone H2A \*                                      FX985611                                   21   
  histone H3 \*                                       FX985610                                        15
  laminin subunit alpha 1 \*                          FX985614           4                  6    5    8
  laminin subunit beta 1 \*                           FX985613                              3    3    9
  laminin subunit gamma 1 \*                          FX985612                                   3    3
  myosin heavy chain, muscle \*                       FX985575           4                  3    11   8
  myosin heavy chain, nonmuscle \*                    FX985578                              2    1    4
  myosin IB \*                                        FX985586                                   11   13
  myosin Ie \*                                        FX985583           5                  7    5    9
  myosin regulatory light chain \*                    FX985576                                        5
  myosin Va \*                                        FX985582           2                  5    4    8
  myosin VIIa \*                                      FX985580                              5    6    5
  myosin XV \*                                        FX985581           5                  5    3    6
  myosin XVIIIa \*                                    FX985584           2                  5    4    3
  resistance to inhibitors of cholinesterase 3 \*     FX986036                                   5    
  transcription factor A, mitochondrial \*            FX985588                                        12
  transmembrane protein 214A \*                       FX986055                              10   4    4
  TRPA channel ^d,^ \*                                FX985591           5                            
  TRPM channel ^d,^ \*                                FX985592           10                 2    5    5
  TRPV channel ^d,^ \*                                FX985593                                        3
  voltage-gated potassium channel Shaker \*           FX985601                              9         
  voltage-gated sodium channel beta subunit TipE \*   FX985590           9                       4    2
  voltage-gated sodium channel Para \*                FX985589                                   2    10

^a^ The coverages were calculated by combining the peptide fragments with the same amino acid sequences and the same molecular masses by Peaks 8.5; ^b^ TR and DTT indicate MS/MS data with or without trypsin digestion and DTT treatment, respectively; ^c^ VEGF: Vascular Endothelial Growth Factor; ^d^ TRPA, TRPM, and TRPV channels are members of the transient receptor potential (TRP) channel superfamily; \* The proteins might be derived from the venom sac.

toxins-11-00050-t002_Table 2

###### 

Amino acid sequences of pilosulin-like peptide derivatives analyzed from MS/MS spectra.

  Toxin                                    Sequence                                     Molecular Mass   Length      Precursor Ion   RT              Intensity
  ---------------------------------------- -------------------------------------------- ---------------- ----------- --------------- --------------- ---------------
  PLP1                                     GILDWGKKVMDWIKDKMGK                          2247.1907        19          750.0702        37.15           3.67 × 10^8^
  GILDWGKKVMDWIKDKMG                       2119.0957                                    18               707.3729    38.28           9.58 × 10^9^    
  GILDWGKKVMDWIKDKM-NH~2~                  2061.0903                                    17               1031.5520   39.15           1.34 × 10^10^   
  GILDWGKKVMDWIKDKM                        2062.0742                                    17               516.5270    38.35           5.74 × 10^8^    
  LDWGKKVMDWIKDKMGK                        2077.0852                                    17               520.2803    34.11           2.65 × 10^8^    
  GILDWGKKVMDWIKDK                         1931.0338                                    16               483.7657    33.21           1.64 × 10^8^    
  LDWGKKVMDWIKDKM-NH~2~                    1890.9849                                    15               631.3347    38.44           1.79 × 10^8^    
  PLP2                                     EAGWGSIFKTVGKMIAKAAVKAAPEAISAMASQNE          3561.8323        35          891.4648        36.4            6.36 × 10^8^
  GWGSIFKTVGKMIAKAAVKAAPEAISAMASQNE        3361.7527                                    33               1121.5916   34.85           6.41 × 10^9^    
  SIFKTVGKMIAKAAVKAAPEAISAMASQNE           3061.6304                                    30               766.4222    27.81           1.12 × 10^9^    
  GWGSIFKTVGKMIAKAAVKAAPEAISAM             2832.5393                                    28               709.1410    34.52           4.53 × 10^8^    
  GWGSIFKTVGKMIAKAAVKAAPEAISA              2701.4988                                    27               676.3826    33.09           6.43 × 10^8^    
  KMIAKAAVKAAPEAISAMASQNE                  2329.2134                                    23               777.4113    17.04           4.98 × 10^8^    
  KAAVKAAPEAISAMASQNE                      1885.9567                                    19               943.9856    15.44           9.06 × 10^8^    
  PLP3                                     KIKWGKIFKKGGKLIGKTALEAAANAAASEAISAMASQNE     4101.2407        40          1026.3179       25.25           4.47 × 10^9^
  KIFKKGGKLIGKTALEAAANAAASEAISAMASQNE      3488.8660                                    35               873.2313    25.16           1.83 × 10^9^    
  KIKWGKIFKKGGKLIGKTALEAAANAAASEAISAM      3572.0276                                    35               894.0147    24.79           2.65 × 10^8^    
  KKGGKLIGKTALEAAANAAASEAISAMASQNE         3100.6187                                    32               776.1608    25.63           2.51 × 10^8^    
  KGGKLIGKTALEAAANAAASEAISAMASQNE          2972.5237                                    31               744.1398    27.22           2.09 × 10^8^    
  GGKLIGKTALEAAANAAASEAISAMASQNE           2844.4287                                    30               949.1498    28.73           5.85 × 10^8^    
  KTALEAAANAAASEAISAMASQNE                 2319.1011                                    24               1160.5585   28.03           1.63 × 10^9^    
  PLP4                                     GVKELFGKAWGLVKKHLPKAC\*GLLGYVKQ              3223.8418        29          806.9683        28.76           1.14 × 10^10^
  GVKELFGKAWGLVKKHLPKAC\*GLL               2648.5352                                    24               663.1436    30.27           2.98 × 10^9^    
  FGKAWGLVKKHLPKAC\*GLLGYVKQ               2697.5305                                    24               675.3940    20.53           5.56 × 10^8^    
  GKAWGLVKKHLPKAC\*GLLGYVKQ                2550.4619                                    23               638.6231    18.8            4.34 × 10^9^    
  AWGLVKKHLPKAC\*GLLGYVKQ                  2365.3457                                    21               789.4556    19.93           6.44 × 10^8^    
  GKAWGLVKKHLPKAC\*GLL                     1975.1553                                    18               659.3927    17.99           6.76 × 10^8^    
  KHLPKAC\*GLLGYVKQ                        1710.9603                                    15               428.7475    16              1.13 × 10^9^    
  PLP5                                     IWGALLGTLIPAITSAIQG                          1894.0928        19          948.0541        43.31           3.50 × 10^8^
  IWGALLGTLIPAITSAIQ-NH~2~                 1836.0873                                    18               919.0532    44.83           7.46 × 10^9^    
  IWGALLGTLIPAITSAIQ                       1837.0713                                    18               919.5428    42.58           3.75 × 10^7^    
  ALLGTLIPAITSAIQ-NH~2~                    1479.9025                                    15               740.9585    36.38           2.25 × 10^8^    
  LLGTLIPAITSAIQ-NH~2~                     1408.8654                                    14               705.4390    34.1            1.45 × 10^8^    
  LLGTLIPAITSA                             1168.7067                                    12               585.3602    30.26           5.15 × 10^6^    
  IWGALLGTLIP                              1152.6907                                    11               577.3530    38.86           1.34 × 10^7^    
  PLP6                                     IKGKKIMKNMGKAMKIAGKVAKAMAPIVVPLIVSAA-NH~2~   3704.2307        36          927.0673        28.61           1.58 × 10^9^
  KIMKNMGKAMKIAGKVAKAMAPIVVPLIVSAA-NH~2~   3277.9353                                    32               820.4910    30.81           8.46 × 10^7^    
  IKGKKIMKNMGKAMKIAGKVAKAMAPIVVPL          3263.9561                                    31               816.9973    23.56           6.27 × 10^8^    
  KNMGKAMKIAGKVAKAMAPIVVPLIVSAA-NH~2~      2905.7158                                    29               727.4368    30              2.21 × 10^8^    
  GKAMKIAGKVAKAMAPIVVPLIVSAA-NH~2~         2532.5376                                    26               845.1871    29.7            1.46 × 10^8^    
  AMKIAGKVAKAMAPIVVPLIVSAA-NH~2~           2347.4211                                    24               587.8628    31.32           1.60 × 10^8^    
  KAMAPIVVPLIVSAA-NH~2~                    1477.9054                                    15               739.9600    31.65           1.18 × 10^8^    
  PLP7                                     GVKELFGKAWGLVKKHLPKAC\*GLMGYVKQ              3241.7983        29          811.4578        28.54           4.63 × 10^9^
  GVKELFGKAWGLVKKHLPKAC\*GLMGY             2886.5764                                    26               722.6530    29.82           5.00 × 10^8^    
  FGKAWGLVKKHLPKAC\*GLMGYVKQ               2715.4868                                    24               679.8821    19.52           5.42 × 10^8^    
  GVKELFGKAWGLVKKHLPKAC\*GLM               2666.4917                                    24               667.6287    29.1            2.48 × 10^9^    
  GKAWGLVKKHLPKAC\*GLMGYVKQ                2568.4185                                    23               643.1163    17.44           4.67 × 10^9^    
  LVKKHLPKAC\*GLMGYVKQ                     2069.1641                                    18               518.2991    13.87           2.37 × 10^7^    
  HLPKAC\*GLMGYVKQ                         1600.8218                                    14               534.6163    16.8            9.41 × 10^8^    
  PLP8                                     FWGALLAAAIPAITSAIQG                          1870.0352        19          936.0242        42.69           2.01 × 10^8^
  FWGALLAAAIPAITSAIQ-NH~2~                 1812.0298                                    18               907.0258    44.13           2.77 × 10^9^    
  GALLAAAIPAITSAIQ-NH~2~                   1478.8820                                    16               740.4485    44.09           2.20 × 10^7^    
  FWGALLAAAIPAITS                          1500.8340                                    15               751.4250    37.82           1.60 × 10^7^    
  ALLAAAIPAITSAIQ-NH~2~                    1421.8606                                    15               711.9372    32.08           7.32 × 10^7^    
  LAAAIPAITSAIQ-NH~2~                      1237.7394                                    13               619.8778    25.83           8.77 × 10^7^    
  AAAIPAITSAIQ-NH~2~                       1124.6553                                    12               563.3350    23.08           2.19 × 10^9^    

C\* = S-(carbamoylmethyl)-L-cysteine. The amino acid sequences of the highest and second-highest intensities are highlighted by red and yellow, respectively.

toxins-11-00050-t003_Table 3

###### 

Biological properties of *O. monticola* pilosulin-like peptides.

  ---------------------------------------------------------------------------------------------------------
  Peptide      MIC ^a^ (μM)   Hemolytic Activity (%)   Histamine-Releasing\                      
                                                       Activity\                                 
                                                       at 10 μM (%)                              
  ------------ -------------- ------------------------ ---------------------- ----------- ------ ----------
  PLP1         \<3.1          \<3.1                    \<50                   Negative    32.9   

  PLP2         \<6.2          \<6.2                    \<50                   Negative    10.4   30.1

  PLP3         \<3.1          \<25                     \<50                   Negative    37.5   

  PLP4         \<3.1          \<3.1                    \<3.1                  Negative    10.5   66.4

  PLP5         \<50           Negative                 Negative               6.9         94.8   28.3

  PLP6         \<3.1          \<3.1                    Negative               Negative    33.6   

  Magainin     \<12.5         \<25                     Negative               \-          \-     

  Mastoparan   \-             \-                       \-                     13.5 ^b^    \-     31.1 ^b^

  Melittin     \-             \-                       \-                     100.0 ^b^   \-     64.3 ^b^
  ---------------------------------------------------------------------------------------------------------

^a^ MIC: minimum inhibitory concentration; ^b^ The activities indicate from Shigeri et al. \[[@B24-toxins-11-00050]\]; -: not determined.
